Lumason Injection, Powder, Lyophilized, For Suspension
NDC Package 0270-7097-08

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Lumason (sulfur hexafluoride) injection is echocardiographyLumason is indicated for use in adult and pediatric patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border.Ultrasonography of the LiverLumason is indicated for use with ultrasound of the liver in adult and pediatric patients to characterize focal liver lesions.Ultrasonography of the Urinary TractLumason is indicated for use in ultrasonography of the urinary tract in pediatric patients for the evaluation of suspected or known vesicoureteral reflux. This formulation utilizes a injection, powder, lyophilized, for suspension delivery system. Marketed by Bracco Diagnostics Inc, this product is identified by NDC 0270-7097 and is authorized under FDA application NDA203684.

Identification & Billing

NDC Package Code
0270-7097-08
Package Description
20 VIAL in 1 BOX / 25 mg in 1 VIAL
Product Code
0270-7097
11-Digit Billing Format
00270709708
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA

Clinical Specifications

Proprietary Name
Lumason
Non-Proprietary Name
Sulfur Hexafluoride
Substance Name
Distearoylphosphatidylcholine, Dl-; Sodium 1,2-dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol); Sulfur Hexafluoride
Dosage Form
Injection, Powder, Lyophilized, For Suspension - A liquid preparation, intended for parenteral use that contains solids suspended in a suitable fluid medium and conforms in all respects to the requirements for Sterile Suspensions; the medicinal agents intended for the suspension are prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures.
Administration Route
  • Intravenous - Administration within or into a vein or veins.
  • Intravesical - Administration within the bladder.
  • Intravenous - Administration within or into a vein or veins.
  • Intravesical - Administration within the bladder.
Active Ingredient(s)
Pharmacologic Class
Usage Information
EchocardiographyLumason is indicated for use in adult and pediatric patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border.Ultrasonography of the LiverLumason is indicated for use with ultrasound of the liver in adult and pediatric patients to characterize focal liver lesions.Ultrasonography of the Urinary TractLumason is indicated for use in ultrasonography of the urinary tract in pediatric patients for the evaluation of suspected or known vesicoureteral reflux.

Regulatory & Marketing

Labeler Name
Bracco Diagnostics Inc
Product Type
Human Prescription Drug
FDA Application #
NDA203684
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
04-01-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Billing & HCPCS Mapping

To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.

Q9950
Source: ASP
Inj sulf hexa lipid microsph
HCPCS Dosage 1 ML
Units / Pkg 100

Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0270-7097). Click a package code to view its specific billing and regulatory data.

0270-7097-07
20 VIAL in 1 BOX / 25 mg in 1 VIAL

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0270-7097-08 identifies a specific commercial package of 20 vial in 1 box / 25 mg in 1 vial of Lumason, a human prescription drug labeled by Bracco Diagnostics Inc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This injection, powder, lyophilized, for suspension is formulated for intravenous; intravesical use and contains distearoylphosphatidylcholine, dl-; sodium 1,2-dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol); sulfur hexafluoride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bracco Diagnostics Inc on April 01, 2021. The current certification is valid through December 31, 2026.

How is this Bracco Diagnostics Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00270709708. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0270-7097-08
11-Digit CMS (5-4-2)
00270-7097-08

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.